MedPath

Diazepam

Diazepam Tablets USP C-IV

Approved
Approval ID

f84b28ff-aae1-4796-a8f0-e06e146235a2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 21, 2020

Manufacturers
FDA

Aphena Pharma Solutions - Tennessee, LLC

DUNS: 128385585

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diazepam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71610-427
Application NumberANDA071136
Product Classification
M
Marketing Category
C73584
G
Generic Name
Diazepam
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 2, 2020
FDA Product Classification

INGREDIENTS (5)

Anhydrous LactoseInactive
Code: 3SY5LH9PMK
Classification: IACT
DiazepamActive
Quantity: 10 mg in 1 1
Code: Q3JTX2Q7TU
Classification: ACTIB
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
Magnesium StearateInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diazepam - FDA Drug Approval Details